A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s81564
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited